Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
Original Article
R. Dummer, A. Hauschild, M. Santinami, V. Atkinson, M. Mandalà, J.M. Kirkwood, V.C. Sileni, J. Larkin, M. Nyakas, C. Dutriaux, A. Haydon, C. Robert, L. Mortier, J. Schachter, T. Lesimple, R. Plummer, K. Dasgupta, E. Gasal, M. Tan, G.V. Long, and D. Schadendorf
N Engl J Med 2020;383:1139-1148
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Saturday, September 17, 2022 - 11:59pm.